Resources from the 2022 NeuroAbilities Virtual Symposium
About the Symposium:
As neurotechnologies (NT), including Brain-Computer Interfaces (BCI), evolve rapidly, what are their pathways to marketable solutions for Persons with Disabilities? What is their market potential? How can their design and applications best serve Persons with Disabilities? How can barriers to adoption be lifted and neuroethics challenges resolved?
The 2022 NeuroAbilities Virtual Symposium explored these issues with experts from different stakeholder groups, featuring keynote presentations from the U.S. Food and Drug Administration, industry leaders, end users, advocates, and funders. The two main pathways for BCI and NT devices development -- as regulated medical devices or unregulated direct-to-consumer (DTC) products – and their specific challenges and opportunities were featured over the course of the Symposium, held from March 30 - April 1, 2022.
Lists of Resource Links Shared by Panelists at the Symposium:
The following lists are compiled from panel sessions over the three (3) days of our Symposium, held from March 30, 2022 - April 1, 2022. For session recordings, please visit our NeuroAbilities YouTube Channel.
- NeuroAbilities YouTube Channel
- NeuroAbilities LinkedIn Group
- G3ict website
- G3ict Twitter
- International Association of Accessibility Professionals (IAAP) website
- IAAP Twitter
Day 1: March 30, 2022
Theme: The Neurotech Opportunity for Persons with Disabilities
- World Intellectual Property Organization (WIPO)
- Lakeshore Foundation
- Touch the Future, Inc.
- Walk2Walk Campaign
- SuitX / Ottobock Bionic Exoskeletons
- Prime Movers Lab
- Center for Inclusive Design and Engineering, University of Colorado Denver
- European Federation of Hard of Hearing People
- International Telecommunications Union
Day 2: March 31, 2022
Theme: Regulatory Frameworks & Alternative Paths for Direct-to-Consumer Technologies
- Blackrock Neurotech
- Department of Physical Medicine and Rehabilitation, University of Pittsburgh
- Center for Devices and Radiological Health at the U.S. Food and Drug Administration (FDA)
- To follow are general resources from the FDA. For the more specific list of resources shared in the PowerPoint slides of our FDA keynote speakers, please visit this page.
- Changes to Existing Medical Software Policies Resulting from Section 3060 of the 21st Century Cures Act
- Requests for Feedback and Meetings for Medical Device Submissions: The Q-Submission Program
- Breakthrough Devices Program
- Investigational Device Exemptions (IDEs) for Early Feasibility Medical Device Clinical Studies, Including Certain First in Human (FIH) Studies
- Digital Health Center of Excellence
- Collaborative Communities Toolkit
- FDA email contacts regarding questions about device regulation: DICE@fda.hhs.gov or DeviceDetermination@fda.hhs.gov
- Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania
Day 3: April 1, 2022
Theme: Disability Rights & Neuroethics
- Leonard Cheshire
- Ian Burkhart Foundation
- Stroke Educator, Inc.
- Occupational Sciences & Technology, College of Health Sciences, University of Wisconsin-Milwaukee
- Rehabilitation Research Design & Disability (R2D2) Center
- Dana Foundation
- Department of Bioethics & Humanities, University of Washington, School of Medicine